ICD-10 Coding for Secondary Immunodeficiency Disorder(D84.821, D84.821B, D84.821I)
Learn about ICD-10 coding for secondary immunodeficiency disorders, including drug-induced cases. Find documentation requirements and coding tips.
Complete code families applicable to Secondary Immunodeficiency Disorder
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D84.821 | Immunodeficiency due to drugs | Use when immunodeficiency is directly linked to drug therapy. |
|
| D84.89 | Other specified immunodeficiencies | Use when immunodeficiency is due to conditions like post-splenectomy or myeloma. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSecondary Immunodeficiency Disorder
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Secondary Immunodeficiency Disorder.
Omitting drug causality in documentation.
Impact
Clinical: Misrepresentation of patient condition., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Review drug therapy history., Ensure lab results support diagnosis.
Incorrect sequencing of drug-induced immunodeficiency codes.
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always sequence the drug toxicity code before D84.821.
Drug-induced immunodeficiency coding
Impact
High risk of audit if drug causality is not documented.
Mitigation
Ensure thorough documentation of drug therapy and lab results.